Status:
COMPLETED
Patient Centered Randomized Controlled Trial
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Early-Stage Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether patient-assistance programs as compared with usual care will help women with early stage breast cancer receive appropriate treatments.
Detailed Description
Numerous trials proved the efficacy of radiation following breast conserving surgery and systemic therapies to increase disease-free and overall survival among women with early-stage breast cancer. Ye...
Eligibility Criteria
Inclusion
- All patients, who are English or Spanish speaking, with a new primary stage 1 or 2 breast cancer who have undergone either breast conserving surgery or mastectomy and those with tumors \>1cm or \<1cm and poorly differentiated;
- All surgeons performing breast surgery at the participating hospitals
Exclusion
- Patients with dementia or those with a poor prognosis due to end-stage organ failure or other concomitant conditions such as those undergoing treatment for other cancers
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
374 Patients enrolled
Trial Details
Trial ID
NCT00233077
Start Date
October 1 2006
End Date
January 1 2011
Last Update
December 3 2013
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Icahn School of Medicine at Mount Sinai
New York, New York, United States, 10029
2
Metropolitan Hospital
New York, New York, United States, 10029
3
Columbia University
New York, New York, United States, 10032
4
Harlem Hospital Center
New York, New York, United States, 10037